Ashland Opens Manufacturing Facility in China

News
Article

Ashland opened a new pharmaceutical excipient manufacturing facility in Nanjing, China.

Ashland announced the opening of the company’s new pharmaceutical excipient facility in Nanjing, China. Senior executives at the company attended a ribbon cutting ceremony for the facility on Oct. 25, 2016. Ashland said in a statement that demand for polymer excipients is rising in China, as the country’s pharmaceutical industry moves to modernize oral drug manufacturing and comply with new quality standards in the 2015 edition of the Chinese Pharmacopoeia.

Ashland said it will make multiple cellulose-based excipients available in China including Klucel HPC, Benecel HPMC, Blanose CMC, and Aqualon EMC. The company also plans to make multiple polyvinylpyrrolidone (PVP)-based polymer excipients available, including Plasdone PVP and Polyplasdone PVPP polymers. All products are sold with a registered pharmaceutical excipient certificate, as required by the China Food & Drug Administration.

Alongside Ashland’s new pharmaceutical excipient production facility in China is an advanced quality control laboratory that contains equipment to measure and analyze products throughout the production process. Instruments, from global suppliers, include Fourier transform infrared spectrometers, liquid chromatography systems, and inductively coupled plasma optical emission spectrometers. The quality control system design and analytical equipment allow Ashland to test all excipient products in accordance with Chinese Pharmacopoeia quality standards.

Source: Ashland

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content